chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.25
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, PNC
Symptoms: Lung disorder, Pneumonia, Respiratory distress
Clinical narrative: Information has been received from an investigator concerning a 3 month old female. On 7/17/02, at 2 months of age, she received her first dose of Prevnar as part of a post-marketing safety surveillance trial. That same day, she also received first doses of DTaP, IPV, and ACT-HIB, with a second dose of Hep B. On 8/28/02, she was hospitalized with acute respiratory distress and a diagnosis of pneumonia was made. Later that day, the child expired due to A/V block complete, acute respiratory failure and heart failure with primary cardiomyopathy and other cardiac dysrhythmias, hypotension, acidosis, and other lung disorders. Resuscitation attempts were unsuccessful. The child's medical history consisted of diaphragmatic/phrenic paralysis with mechanical ventilation leading to chronic lung disease, meconium aspiration and pulmonary hypertension which required extracorporeal circulation membrane oxygenation, pylorospasm, and feeding problems which required feedings via N-J tube. The investigator's assessment of relatedness of these events (all except pneumonia, unexpected as per USPI) to the vaccines administered was *not related.* *Add'l info received as result of combining duplicate cases on 12/13/02 provided an investigator's assessment of NOT RELATED."*
Sex: M
Vaccine: DTP, HIBV
Symptoms: Drug toxicity, Mental retardation severity unspecified, Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: A legal complaint was received on 12/3/02 from an attorney alleging that a child received series of Hep B (manuf unk), Engerix B, Tripedia vaccines as well as Hib-TITER and Tri-Immunol vaccines from 10/16/96 through 10/19/98 and subsequently suffered "from the toxic neurological effects of mercury poisoning." According to the legal complaint, the child experienced "mental and intellectual incapacity, developmental incapacity, learning disabilities, and affect disorders and impairments." The pt's symptoms resulted in persistent or significant disability/incapacity. Vaccination info contained in the legal complaint indicated that the child received hep B, Engerix B, Tripedia, Hib-TITER, and Tri-Immunol vaccines during the first years of his life.
Sex: M
Vaccine: DTP, HIBV
Symptoms: Drug toxicity, Mental retardation severity unspecified, Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: Information has been received 12/3/02 via legal complaint from an attorney concerning a male pt who received series of Hib vaccines (manuf not stated), DTP vaccines (manuf not stated), and hep B (manuf not stated ) from August 1997 through October 1998 and experienced "the toxic neurological effects of mercury poisoning." Legal complaint also states that the pt experienced "mental and intellectual incapacity, developmental incapacity, learning disabilities, and affect disorders and impairments." The pt's symptoms resulted in persistent or significant disability/incapacity.
Sex: M
Vaccine: DTP, HIBV
Symptoms: Drug toxicity, Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: An attorney reported that a male child received a series of mercury containing vaccines including Hib (manuf unk), Tetramune, DTP (manuf unk), and hep B from March 1998 through June 1999. It is alleged that, as a result of the "high mercury exposure levels" from the vaccines he received, the child "has developed severe neurodevelopmental disorders" and "has suffered serious permanent injury." No further info was available as of the date of this report.
Sex: M
Vaccine: HIBV
Symptoms: Drug toxicity, Mental retardation severity unspecified, Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: A legal complaint was received from an attorney alleging that a female child received Hib-TITER, Tetramune, Acel0Imune, and Recombivax-HB from October 1995 through March 1997. According to the legal complaint, the child "has developed severe neurodevelopmental disorders with associated high mercury exposure levels as a result of the vaccinations she received," due to the cumulative exposure to the mercury preservative thimerosal in the vaccines. According to the legal complaint, the child "has sustained mental, intellectual, developmental and neurological incapacity and associated learning disabilities, affect disorders and impairments." It is also alleged that the child has "suffered serious permanent injury." No further info was available as of the date of this report. The lot number given for Tetramune, 4270840, administered 10/20/95 (as per the legal complaint), is not a valid lot number. This case was serious since these events were considered medically important (OMIC).
Sex: M
Vaccine: DTAP, HIBV
Symptoms: Drug toxicity, Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: A legal complaint was received from an attorney alleging that a male child received Hib-TITER, Acel-Imune, and hep B vaccines from April 1999 through July 2000. According to the legal complaint, the child subsequently "was poisoned" by the cumulative doses of the mercury preservative, thimerosal, in the vaccines. It is alleged that the child "now suffers, and in the future will continue to suffer, from the toxic neurolgoical effects of mercury poisoning." No further info was available at the date of this report. This case was serious since these events are considered medically important (OMIC).
Sex: U
Vaccine: DTP, HIBV
Symptoms: Drug toxicity, Mental retardation severity unspecified, Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: A legal complaint was received from an attorney alleging that a child received series of HibTITER, DTP, and Engerix B vaccines "from October 2000 through at least January 2002." The complaint alleges that "As a result of the mercury in the Thimerosal-containing vaccinations that Minor Child received, Minor Child now suffers, and in the future will continue to suffer, from the toxic neurolgoical effects of mercury poisoning." According to the complaint, the child "has sustained mental, intellectual, developmental and neurological incapacity and associated learning disabilities, affect disorders and impairments." The complaint alleges that the child "has sustained permanent, severe physical injuries, requiring medical care ad treatment." No further info was available at the dat eof this report.
Sex: U
Vaccine: DTP, HIBV
Symptoms: Drug toxicity, Mental retardation severity unspecified, Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: A legal complaint was received from an attorney alleging that a child received series of Tetramune and hep B vaccines as well as doses of HibTITER, DTP, Engerix B, and DT vaccines from January 1995 through at least August 2000 and subsequently "developed severe neurodevelopmental disorders with associated high mercury exposure levels as a result of the vaccinations he received, and has suffered serious permanent injury." It is alleged that "As a result of the mercury in the Thimerosal-containing vaccinations that Minor Child received, Minor Child now suffers, and in the future will continue to suffer, from the toxic neurological effects of mercury poisoning." According to the legal complaint, "the Minor Child has sustained mental, intellectual, developmental and neurological incapacity and associated learning disabilities, affect disorders and impairments." No further info was available at the date of this report.
Sex: M
Vaccine: DTP, HIBV
Symptoms: Drug toxicity, Mental retardation severity unspecified, Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: A legal complaint was received from an attorney who alleges that a male child received a series of haemophilus B conjugate (manuf unk), DPT (manuf unk), and hep B (manuf unk) vaccines between 8/8/94 through 9/9/99. According to the legal complaint, the "child suffers, and in future will continue to suffer from the toxic neurological effects of mercury poisoning." These injuries reportedly include "mental, intellectual, developmental and neurological incapacity and associated learning disabilities, affect disorders and impairments." The reporter claims that these injuries have resulted in a "permanent disability."
Sex: U
Vaccine: HIBV
Symptoms: Drug toxicity, Mental retardation severity unspecified, Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: A legal complaint was received from an attorney alleging that a child received series of Hib (manuf unk), DTaP (manuf unk), and hep B (manuf unk) vaccines as well as doses of Tetramune and Engerix B vaccines from April 1999 through at least October 2000 and subsequently "developed severe neurodevelopmental disorders with associated high mercury exposure levels as a result of the vaccinations he received, and has suffered serious permanent injury." It is alleged that "As a result of the mercury in the Thimerosal-containing vaccinations that Minor Child received as an infant, Minor Child now suffers, and in the future will continue to suffer, from the toxic neurological effects of mercury poisoning." According to the legal complaint, "the Minor Child has sustained mental, intellectual, developmental and neurological incapacity and associated learning disabilities, affect disorders and impairments." No further info was available at the date of this report.
Age: 50.0
Sex: M
Vaccine: FLU3
Symptoms: Anaemia, Deep vein thrombosis, Hyperglycaemia, Myelitis transverse, Paralysis
Clinical narrative: Dx transverse meylitis 12/7/02. Sudden onset. Etiology not known. Received two flu vaccines 10/08/2002, 11/07/2002. 60 day follow up states pt has not recovered. Transverse myelitis- no change in symptoms. The annual follow up received on 1/13/04 states persistent paralysis. Discharge summary states deep vein thrombosis. msv Medical records state anemia, urinary retention, urinary infection. msv
Age: 50.0
Sex: M
Vaccine: FLU3
Symptoms: Thrombocytopenia, Urinary retention, Urinary tract infection
Clinical narrative: Dx transverse meylitis 12/7/02. Sudden onset. Etiology not known. Received two flu vaccines 10/08/2002, 11/07/2002. 60 day follow up states pt has not recovered. Transverse myelitis- no change in symptoms. The annual follow up received on 1/13/04 states persistent paralysis. Discharge summary states deep vein thrombosis. msv Medical records state anemia, urinary retention, urinary infection. msv
Age: 2.0
Sex: M
Vaccine: DTAP, HIBV, IPV
Symptoms: Abnormal behaviour, Agitation, Antisocial behaviour, Autism, Cognitive disorder
Clinical narrative: After DPT high pitched screaming and swollen injection site, slow development became autistic approx 1 1/2 year old. There is no specific date of injury. His vaccine indured autism was due to cumulative vaccinations with mercury in them. A marked impairment in the use of multiple nonverbal behaviors, such as eye-to-eye gaze, facial expression, body postures, and gestures, to regulate social interaction. Failure to develop peer relationships appropriate to developmental level. Lack of social or emotional reciprocity. Delay in, or total lack of, the development of spoken language. Lack of spontaneous make-believe, or social imitative play appropriate to developmental level. Stereotyped and repetitive motor mannerisms. Persistent preoccupation with parts of objects. Slow onset. Happened right after first DPT, then went away. Then sometime after age 12 months gradually lost eye contact around 18 months lost ? 2 years lost social. 60 day follow up states pt has not recovered. Autism, immune disorder.
Age: 2.0
Sex: M
Vaccine: DTAP, HIBV, IPV
Symptoms: Crying, Drug toxicity, Immune system disorder, Injection site oedema, Neurodevelopmental disorder
Clinical narrative: After DPT high pitched screaming and swollen injection site, slow development became autistic approx 1 1/2 year old. There is no specific date of injury. His vaccine indured autism was due to cumulative vaccinations with mercury in them. A marked impairment in the use of multiple nonverbal behaviors, such as eye-to-eye gaze, facial expression, body postures, and gestures, to regulate social interaction. Failure to develop peer relationships appropriate to developmental level. Lack of social or emotional reciprocity. Delay in, or total lack of, the development of spoken language. Lack of spontaneous make-believe, or social imitative play appropriate to developmental level. Stereotyped and repetitive motor mannerisms. Persistent preoccupation with parts of objects. Slow onset. Happened right after first DPT, then went away. Then sometime after age 12 months gradually lost eye contact around 18 months lost ? 2 years lost social. 60 day follow up states pt has not recovered. Autism, immune disorder.
Age: 33.0
Sex: U
Vaccine: ANTH
Symptoms: Injection site reaction, Rash erythematous
Clinical narrative: 20 cm X 13 cm Erythematous rash over right deltoid, Tx: Lidex cream and Claritin,  48 hours later rash completely gone and patient doing well
Age: 30.0
Sex: M
Vaccine: ANTH
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Tricep swelled up twice size, burning pain
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Hypersensitivity, Hypokinesia, Oedema peripheral, Pain
Clinical narrative: Early am 11/15/02 awoke to terrible itching on hands. Hives were prominent. Before 11:00am, hands were very swollen, 11/15/02 Went to doctor, Got medicine for itching hives. Sunday evening 11/11/1987 went to ER-Excessive pain in shoulders and wrists, Could not move arms, Pain medication given, Checked by physician on Wed 11/20, still signs of swelling, From that time to present have had swelling and pain in joints of both hands, Right  hand has numbness.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus, Urticaria
Clinical narrative: Early am 11/15/02 awoke to terrible itching on hands. Hives were prominent. Before 11:00am, hands were very swollen, 11/15/02 Went to doctor, Got medicine for itching hives. Sunday evening 11/11/1987 went to ER-Excessive pain in shoulders and wrists, Could not move arms, Pain medication given, Checked by physician on Wed 11/20, still signs of swelling, From that time to present have had swelling and pain in joints of both hands, Right  hand has numbness.
Age: 59.0
Sex: F
Vaccine: FLU3
Symptoms: Myalgia, Oedema
Clinical narrative: 11/18/02 Employee received flu shot and had an adverse reaction 1 hour later. She returned to the flu clinic "complained of swelling, intense aching of left arm where flu shot was administered. Employee sent to occupational health services and seen by RN who sent employee to ER for further treatment. No SOB or respiratory problems were present. Area was ? free of redness or firmness. Sent home after treated without further problems.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Dyspnoea, Injection site hypersensitivity, Oedema, Pruritus
Clinical narrative: Less than 10 minutes, patient report itching and burning at injection site. Left deltoid red, warm and swollen approximately 40-50mm. No SOB or hives. Ice applied. One hour later patient reports mild SOB and scratchy throat. Antihistamine given. No hives.
Age: 63.0
Sex: F
Vaccine: PPV
Symptoms: Oedema, Pain, Urticaria, Vasodilatation
Clinical narrative: Severe local reaction - hives and swelling from elbow to shoulder. Slightly warm to touch, very painful. No fever.
Age: 47.0
Sex: F
Vaccine: FLUX
Symptoms: Unevaluable event
Clinical narrative: Allergy to eggs, severe shock, stuffiness ? shot. Benadryl
Sex: M
Vaccine: FLUX, MMR, VARCEL
Symptoms: Screaming
Clinical narrative: Patient visiting from Sacramento area. Seven days after receiving MMR(11/15/02) Had 2.5 hours of high pitched screaming inconsolable. Next day fine. Normal
Sex: M
Vaccine: MMR
Symptoms: Erythema, Injection site mass, Respiratory disorder
Clinical narrative: Patient had a MMR vaccine. Twenty minutes after vaccine, patient had erythematous(macular) flushing on face, back, legs with erythema and induration around injection site. He was given EPI SG1:1000 .1cc at 155pm and Benadry 12.5mg 1M 2pm. During period of observation, there was no wheezing, however patient had a small amount of upper airway noise. Vital signs remained stable throughout and patients lips were pink. Because of mild upper airway noise, patient was transferred via ambulance to ER. By the time that he arrived there, he was asymptomatic from a respiratory standpoint. He was observed, given Prelone orally, and sent home. He took Prelone for 3 days total. He was seen in office on 12/6/02 with a normal examination.
Age: 6.0
Sex: M
Vaccine: DTAP, HEP, IPV, MMR
Symptoms: Oedema, Pain, Pruritus, Vasodilation procedure
Clinical narrative: Child received immunizations on 11/27/02. That evening child complained of pain and itching in the right arm. The arm is swollen from the shoulder to the elbow, warm to touch and red.
Age: 20.0
Sex: M
Vaccine: HEP, HEPA, IPV
Symptoms: Rash
Clinical narrative: 12-4-02 Received HBV #2, HAV #1, IPV. 12-5-02 rash develops upper part of body. 12-9-02 no other sx developed. Rash still visible but improving.
Age: 45.0
Sex: F
Vaccine: FLU3
Symptoms: Ear pain
Clinical narrative: Pressure behind right ear radiating alongside of right neck area, pressure of right ear, facial mask of right side.
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Pruritus
Clinical narrative: Developed about 50 vesicles over a period of 12 hours. Complained of itching.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Pyrexia, Urticaria
Clinical narrative: Fever followed by urticarial rash that lasted 5 days following DTaP and IPV.
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Drug ineffective, Rash vesicular
Clinical narrative: Chicken pox of more than 50 pox all over patient's body observed by a provider at clinic.
Age: 52.0
Sex: F
Vaccine: TTOX
Symptoms: Injection site erythema, Injection site swelling, Pain
Clinical narrative: Developed local swelling and redness after injection. Some pain.
Age: 1.3
Sex: M
Vaccine: DTAP, HIBV, MMR, VARCEL
Symptoms: Night sweats, Pruritus, Pyrexia, Rash
Clinical narrative: Rash since yesterday. Has had fever past 2 days; night sweats. No N/V/D. No other symptoms. Pruritis.
Age: 1.2
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR
Symptoms: Bacterial infection, Pyrexia, Swelling, Tenderness
Clinical narrative: Maternal grandmother reports fever of 101 F and significant swelling and tenderness of right mandible area. Child eating and drinking normally; fever successfully lowered with acetaminophen. Family to monitor and seek medical attention if symptoms persist or worsen. 11/27 Child seen in ED; diagnosed with Strept; put on antibiotic.
Age: 18.0
Sex: F
Vaccine: TD
Symptoms: Dysphonia, Paraesthesia, Pruritus, Pyrexia, Thermal burn
Clinical narrative: 9/6/02 Patient developed pruritis on neck and jaw line. Also hoarse voice. Temperature 102F. No rush. Also positive burning and tingling sensation jawline and neck.
Age: 52.0
Sex: F
Vaccine: LYME
Symptoms: Bone disorder
Clinical narrative: Osteopenia in hands; lumbar spine; right hip; monocloxial gammapothy (pre-cursor to bone marrow cancer). All happened since series of shots. Patient now in cancer center.
Sex: M
Vaccine: MMR
Symptoms: Erythema, Pruritus
Clinical narrative: Red, itchy bumps on torso.
Sex: M
Vaccine: HEP
Symptoms: Drug toxicity, Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in a male child of unspecified age who was vaccinated with hep B vaccine recombinant (Engerix B) for prophylaixs. This report was received as part of litigation proceedings and has not been verified by a physician or other healthcare professional. The subject's medical history, concurrent conditions, and concurrent medications were not reported. The subject received injections of hep B vaccine on 1/9/95 and 2/8/95. He received an injection of Engerix B on 9/28/95 (lot 1513B2). He also received injections of Tetramune 2/8/95, 4/13/95 and 6/21/95, DTP 4/4/96, Hib-Titer 4/4/96, and DT 8/11/00. The subject's attorney alleged that "As a result of the mercury in the Thimerosal-containing vaccinations that the subject received, he now suffers, and in the future will continue to suffer, from the toxic neurological effects of mercury poisoning." The attorney further alleged that the subject "has developed severe neurodevelopmental disorders with associated high mercury exposure levels as a result of the vaccinations he received, and has suffered serious permanent injury." Onset and treatment of the events were not specified. The mercury poisoning in this report, with resultant neurodevelopmental disorders, is considered medically serious (OMIC).
Sex: M
Vaccine: HEP
Symptoms: Drug toxicity, Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in a male child of unspecified age who was vaccinated with hep  B vaccine (manuf unk) for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other healthcare professional. The subject's medical history, concurrent conditions, and concurrent medications were not reported. The subject received an injections of hep B vaccine (manuf unk) on 8/7/97, 11/10/97, and 4/21/98. He also received injections of diphtheria and tetanus toxoids and pertussis vaccine (manuf unk) 9/18/97, 10/10/97, 1/30/98, and 10/23/98 and Haemophilus influenzae type B conjugate vaccine (manuf unk) 9/18/97, 11/10/97, 1/30/98 and 10/23/98. The subject's attorney alleged that "As a result of the mercury in the Thimerosal-containing vaccinations that the subject received he now suffers, and in the future will continue to suffer from the toxic neurological effects of mercury poisoning." The attorney further alleged that the subject "has developed severe neurodevelopmental disorder with associated high mercury exposure levels as a result of the vaccinations he received, and has suffered serious permanent injury." Onset and treatment of the events were not specified. The mercury poisoning in this report, with resultant neurodevelopmental disorders, is considered medically serious (OMIC).
Sex: M
Vaccine: HEP
Symptoms: Drug toxicity, Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in a male child of unspecified age who was vaccinated with hep B vaccine recombinant (Engerix B) for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other healthcare professional. The subject's medical history, concurrent conditions, and concurrent medications were not reported. The subject received an injection of Engerix B (lot 2499A2) on 3/9/98. He also received injections of hep B vaccine (manuf unk) 9/14/98, diphtheria and tetanus toxoids and pertussis vaccine (manuf unk) 5/8/98, 7/8/98 and 6/18/99, Tetramune 9/14/98 and haemoophilus influenzae type B conjugate vaccine (manuf unk) 6/18/99. The subject's attorney alleged that "As a result of the mercury in the Thimerosal-containing vaccinations that the subject received he now suffers, and in the future will continue to suffer, from the toxic neurological effects of mercury poisoning." The attorney further alleged that the subject "has developed severe neurodevelopmental disorders with associated high mercury exposure levels as a result of the vaccinations he received, and has suffered serious permanent injury." Onset and treatment of the events were not specified. The mercury poisoning in this report, with resultant neruodevelopmental disorders, is considered medically serious (OMIC).
Sex: M
Vaccine: HEP
Symptoms: Drug toxicity, Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in a male child of unspecified age who was vaccinated with hep B vaccine recombinant (Engerix B) for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other healthcare professional. The subject's medical history, concurrent conditions, and concurrent medications were not reported. The subject received an injection of Engerix B (lot 2712A2) on 4/18/99. He also received injections of hep B vaccine (manuf unk) 6/18/99 and 12/16/99, DTaP (manuf unk) 6/18/99, 10/18/99, and 10/18/00, Tetramune 8/17/99, and haemophilus influenzae type B conjugate vaccine (manuf unk) 6/18/99, 10/18/99 and 4/18/00. The subject's attorney alleged that "As a result of the mercury in the Thimerosal-containing vaccinations that the subject received he now suffers, and in the future will continue to suffer, from the toxic neurological effects of mercury poisoning." The attorney further alleged that the subject "has developed severe neurodevelopmental disorders with associated high mercury exposure levels as a result of the vaccinations he received, and has suffered serious permanent injury." Onset and treatment of the events were not specified. The mercury poisoning in this report, with resultant neurodevelpemntal disorders, is considered medically serious (OMIC).
Sex: M
Vaccine: HEP
Symptoms: Drug toxicity, Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in a male child of unspecified age who was vaccinated with hep B vaccine recombinant (Engerix B) for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other healthcare professional. The subject's medical history, concurrent conditions, and concurrent medications were not reported. The subject received an injection of Engerix B (lot 1722A; not a complete lot number) on 9/14/95. He also received injections of hep B vaccine (manuf unk) 11/14/95 and 9/25/96, Tetramune 11/14/95, 1/18/96, and 4/9/96. Haemophilus influenzae type B conjugate vaccine (manuf unk) 1/28/97, and DTP vaccine (manuf unk) 7/3/97. The subject's attorney alleged that "As a result of the mercury in the Thimerosal-containing vaccinations that the subject received he now suffers, and in the future will continue to suffer, from the toxic neurological effects of mercury poisoning." The attorney further alleged that the subject "has developed severe neurodevelopmental disorders with associated high mercury exposure levels as a result of the vaccinations he received, and has suffered serious permanent injury." Onset and treatment of the events were not specified. The mercury poisoning in this report, with resultant neurodevelopmental disorders, is considered medically serious (OMIC).
Sex: M
Vaccine: HEP
Symptoms: Drug toxicity, Nervous system disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in a male child of unspecified age who was vaccinated with hepatitis B vaccine recombinant (Engerix B) for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other healthcare professional. The subject's medical history, concurrent conditions, and concurrent medications were not reported. The subject received an injection of Engerix-B on 12/31/92, 1/29/93, 9/30/93, and 1/23/97. He also received injections of diphtheria and tetanus toxoids and pertussis vaccine, Haemophilus influenzae type B vaccine, combination diphtheria and tetanus toxoids and pertussis vaccine/Haemophilus influenzae type B conjugate vaccine, and influenza virus vaccine. The subject's attorney alleged that as a result of the mercury in the Thimerosal-containing vaccinations that the subject received he now suffers and in the future will continue to suffer, from the toxic neurological effects of mercury poisoning. The attorney further alleged that the subject has developed severe neurodevelopmental disorders with associated high mercury exposure levels as a result of the vaccinations he received, and has suffered serious permanent injury. Onset and treatment of the events were not specified. The mercury poisoning in this report, with resultant neurodevelopmental disorders, is considered medically serious.
Sex: M
Vaccine: DTP, HEP, HIBV
Symptoms: Drug toxicity, Nervous system disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in a male child of unspecified age who was vaccinated with hepatitis B vaccine for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other healthcare professional. The subject's medical history, concurrent conditions, and concurrent medications were not reported. The subject received injections of hepatitis B vaccine on 8/8/94 and 9/27/94. He also received injections of diphtheria and tetanus toxoids and pertussis vaccine 9/27/94, 12/6/94, 3/3/95, 12/13/95, and 9/9/99 and Haemophilus influenzae type B conjugate vaccine 9/27/94, 12/6/94, 3/3/95, and 12/13/95. The subject's attorney alleged that as a result of the mercury in the thimerosal containing vaccinations that the subject received, he now suffers and in the future will continue to suffer, from the toxic neurological effects of mercury poisoning. The attorney further alleged that the subject has developed severe neurodevelopmental disorders with associated high mercury exposure levels as a result of the vaccinations he received, and has suffered serious permanent injury. Onset and treatment of the events were not specified. The mercury poisoning in this report, with resultant neurodevelopmental disorders is considered medically serious (OMIC).
Sex: M
Vaccine: HEP
Symptoms: Drug toxicity, Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in a male child of unspecified age who was vaccinated with hep B vaccine recombinant (Engerix B) for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other healthcare professional. The subject's medical history, concurrent conditions, and concurrent medications were not reported. The subject received injections of Engerix B on 2/19/01 (lot 5168A2) and 1/29/02 (lot 5252A2). He also received injections of Tripedia 12/12/00 and 2/19/01 and Hib-Titer 10/10/00 and 12/12/00. The subject's attorney alleged that "As a result of the mercury in the Thimerosal-containing vaccinations that the subject received, he now suffers, and in the future will continue to suffer, from the toxic neurological effects of mercury poisoning." The attorney further alleged that the subject "has developed severe neurodevelopmental disorders with associated high mercury exposure levels as a result of the vaccinations he received, and has suffered serious permanent injury." Onset and treatment of the events were not specified. The mercury poisoning in this report, with resultant neurodevelopmental disorders, is considered medically serious (OMIC).
Sex: F
Vaccine: DTPHIB, HEP
Symptoms: Drug toxicity, Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in a female child of unspecified age who was vaccinated with hep B vaccine recombinant (Engerix B) for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other healthcare professional. The subject's medical history, concurrent conditions, and concurrent medications were not reported. The subject received injections of Engerix B on 1/4/95 (lot 1513B2)( and 2/8/96 (lot 1950A2). She also received injections of Tetramune 2/8/96 and Tri-Immunol 4/22/96. The subject's attorney alleged that "As a result of the mercury in the Thimerosal-containing vaccinations that the subject received she now suffers, and in the future will continue to suffer, from the toxic neurological effects of mercury poisoning." The attorney further alleged that the subject "has developed severe neurodevelopmental disroders with associated high mercury exposure levels as a result of the vaccinations she received, and has suffered serious permanent injury." Onset and treatment of the events were not specified. The mercury poisoning in this report, with resultant neurodevelopmental disorders, is considered medically serious (OMIC).
Sex: F
Vaccine: HEP
Symptoms: Headache, Injection site erythema, Lethargy, Nausea, Vomiting
Clinical narrative: A nurse reported the occurrence of lethargy in an approximately 18 to 20 year old female who was vaccinated with hep B vaccine recombinant (Engerix B) for prophylaxis. The subject had no known drug allergies. Concurrent conditions were not reported. There were no concurrent medications or vaccines. The subject experienced no adverse events following previous immunizations. On 12/5/02, the subject received her second Engerix B injection. She "immediately developed a red line that started at the site of injection and continued to her neck. It did not follow a vein or artery." Approximately two hours post-immunization, the subject experienced nausea, vomiting, "severe" headache, and lethargy. The subject was examined in the emergency room and hospitalized. Computed tomography and lumbar puncture have "shown nothing." The subject remained hospitalized as of 12/9/02. The red line persisted; the outcomes of the other reported events were not known. The reporting nurse considered the events to be probably related to Engerix B administration. The nurse stated that the subject's physicians "believe it is due to a bad lot rather than a hypersensitivity reaction." The Engerix B immunization series was discontinued.  Reported on 03/25/2003: "The most recent information was received on 03/18/2003.  The erythema had resolved.  The outcomes of the other reported events were not specified.  The reporter indicated that the subject returned to work after an approximately six-week leave of absence.  Therefore, the events are considered to be persistently incaparitating.
Age: 13.0
Sex: F
Vaccine: HEP
Symptoms: Autism
Clinical narrative: This report describes the occurrence of "classic symptoms of autism" in a 13 year old female who was vaccinated with hep B vaccine (manuf unk) for prophylaxis. This report was received from the subject's mother and has not been verified by a physician or other health care professional. The subject's medical history, concurrent conditions, and concurrent medications were not reported. On 7/25/00, the subject reportedly received her first injection of hep B vaccine (manuf unk). It was reported that the subject subsequently received her second and third injections of hep B vaccine on unspecified dates. The mother stated that at an unspecified time after the third injection of vaccine, her daughter experienced "classic symptoms of autism," which she stated, "are similar to mercury poisoning." As of 12/2/02, the symptoms reportedly persisted. The reporter declined to provide additional info and declined to grant manufacturer authorization to contact the subject's physician. Therefore, additional info will not be available. The "classic symptoms of autism" in this report are considered medically serious (OMIC).
Sex: M
Vaccine: DTP, HEP
Symptoms: Drug toxicity, Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: This report describes the occurrence of mercury poisoning in a male child of unspecified age who was vaccinated with hep B vaccine (Engerix B) for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other healthcare professional. The subject's medical history, concurrent conditions, and concurrent medications were not reported. The subject received an injection of hep B vaccine (manuf unk) on 10/16/96. He received injections of Engerix B on 12/9/96 (lot 2137A2) and 4/29/97 (2149A2). He also received injections of Tri-Imunol 12/9/96, 4/29/97, 2/26/98 and 10/19/98 and Hib-Titer /29/97 and 10/19/98. The subject's attorney alleged that "As a result of the mercury in the Thimerosal-containing vaccinations that the subject received he now suffers, and in the future will continue to suffer, from the toxic neurological effects of mercury poisoning. " The attorney further alleged that the subject "has developed severe neurodevelopmental disorder with associated high mercury exposure levels as a result of the vaccinations he received and has suffered serious permanent injury." Onset and treatment of the events were not specified. The mercury poisoning in this report, with resultant neurodevelopmental disorders, is considered medically serious (OMIC).
Age: 0.4
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Cyanosis
Clinical narrative: Convulsions, perioral cyanosis upper and lower extremities.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV
Symptoms: Cellulitis, Injection site erythema, Injection site induration
Clinical narrative: Right deltoind erythematous with induration 3"x4"at 36 hours out from DTaP, IPV site. Started on augmentin 400mg Q 12 hours and Benadryl 2tsp PO Q 6 hours. Follow up 24 hours at clinic. Dx cellulitis.
Age: 0.2
Sex: M
Vaccine: DTAP
Symptoms: Agitation, Crying, Hypotonia, Pyrexia, Stupor
Clinical narrative: Hypotonic/hyporesponsive-within two hours of vaccine lasting approximately 40 hrs. Fever 100 deg F (rectal) within one hour of vaccine lasting approximately 42 hrs. Gave Tylenol  and mainly following innoculation and continues every four hours. many visits to dr's office thee two days. DTaP=only vaccine given. Also tired giving Motrin but this caused severe screaming lasting approximately 20 to 30 minutes each time.
Age: 2.0
Sex: F
Vaccine: UNK
Symptoms: Dermatitis bullous, Erythema, Pruritus
Clinical narrative: Red itchy pox presented on abd, leg and buttocks.
Age: 3.6
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Injection site rash
Clinical narrative: Red rash at injection site-non tender. Two weeks ago received varicella.
Age: 39.0
Sex: F
Vaccine: TD
Symptoms: Rash, Skin nodule
Clinical narrative: Small rash on L arm and small knot occurred couple of days post Td shot given.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Upper arm red and swollen-no fever, not ill.
Age: 55.0
Sex: F
Vaccine: UNK
Symptoms: Chills, Headache, Influenza like illness, Malaise, Pain
Clinical narrative: Chills, aches 20 hrs post shot, fever/chills (102 degrees temp) body aches, headache, flu symptoms 24 hrs-48 hrs post shot-malaise for following day.
Age: 55.0
Sex: F
Vaccine: UNK
Symptoms: Pyrexia
Clinical narrative: Chills, aches 20 hrs post shot, fever/chills (102 degrees temp) body aches, headache, flu symptoms 24 hrs-48 hrs post shot-malaise for following day.
Age: 1.6
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Dermatitis bullous, Infection, Pyrexia
Clinical narrative: She got the chicken pox after receiving the vaccination. Red spots. High fever for 24 hrs (101 degrees). Lasted one week (7 days). No treatment necessary. Didn't seem to itch.
Age: 1.6
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Injection site erythema, Injection site oedema, Injection site reaction, Injection site warmth
Clinical narrative: Rt thigh-small local reaction. Red, swelling, warm to touch.
Age: 1.25
Sex: F
Vaccine: MMR
Symptoms: Irritability, Rash macular, Rash morbilliform, Rash papular
Clinical narrative: Pt developed a maculopapular rash and irritability which started on day #15 following her MMR injection. She did not have fever. She was examined on day #18 and had what appreared to be a mobilliform rash on the trunk.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Unevaluable event
Clinical narrative: Patient received vaccines 10/11/02. DPT and IPV left upper arm. Presented to ER 10/13/02.
Age: 1.5
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site oedema, Injection site warmth
Clinical narrative: 4" diameter, redness, swelling, warm to touch Not using arm well. Antibiotic treatment needed-Keflex 5cc tid x 10 days
Age: 5.0
Sex: M
Vaccine: UNK
Symptoms: Unevaluable event
Clinical narrative: Cannot complete report due to insufficient info. from previous Dr.
Age: 17.0
Sex: M
Vaccine: YF
Symptoms: Tongue oedema
Clinical narrative: No fever. States tongue was slightly swollen 2-3 days after injection. Taste buds were swollen for about 5-6 days. Saw doctor in office. Strept test done at that time 11/18/02; was better 11/19/02. Had told doctor that he had a yellow fever shot prior to onset. Doctor reassured him that he was ok. No difficulty breathing. We suggested that before considering getting another yellow fever shot after 10 years that he confer with physician at that time.
Age: 24.0
Sex: F
Vaccine: FLUX
Symptoms: Chills, Dizziness, Feeling hot, Flushing
Clinical narrative: Patient flushed, dizzy - left ear flushed.  Patient felt very hot, then chills.
Age: 21.0
Sex: F
Vaccine: MMR
Symptoms: Cardiac disorder, Fatigue, Heart rate increased, Nausea, Vomiting
Clinical narrative: On 12/28/01 patient went to the urgent care with complaints of nausea, vomiting, fatigue and rapid heart beat.  Was treated with an OTC medication and given referral to see Cardiology.  Rapid heart beat continued which also caused pt. to feel breathless on exertion.  Cardiology performed echocardiogram and found to have minor Mitral Regurgitation.  Was prescribed Toprol, however, pt. didn't tolerate this.  Developed migratory joint pain and swelling with muscle aches in mid January.  2/6/02 was evaluated by Rhematology with a dianosis of Reactive Artritis.  Was followed and treated with NSAID's and Prednisone.  Pt. tolerated NSAID's the best and was felt to have resolved reactive arthritis on visit of 6/27/02
Age: 32.0
Sex: M
Vaccine: ANTH
Symptoms: Headache, Nausea
Clinical narrative: 1.5 hours after receiving the anthrax shot he developed a bifrontal headache with nausea.
Age: 3.0
Sex: M
Vaccine: DTAP
Symptoms: Erythema, Oedema, Pyrexia
Clinical narrative: Right leg swollen and reddened down into knee area since the shot - mother states.  He initially came down with a fever of 103 degrees at 1AM 12/14/2002, then on 12/15/2002 @7:30 PM the swelling in the leg was noted.  I was notified on Monday 12/16/2002 at 4:45 PM - I referred the patient to their PMD and mother made an appt. for 12/17/2002 at 4PM
Age: 21.0
Sex: M
Vaccine: HEPA, TYP
Symptoms: Blister, Dry skin
Clinical narrative: I received the first three injections of Anthrax on 28 June 1999, 12 July 1999, and 26 July 1999.  I noticed after I got the shots that I started getting dry skin on my right hand and small fluid filled blisters on one finger that also developed over time.  My skin on two fingers of my right hand also cracked and peeled progressively. It became worse.  It is now covering my both hands and both ankles.  I have tried treatment of all kinds and nothing has worked.  I believe my skin problems are related to me receiving the anthrax shots.  Although I did not catch the skin version of the anthrax, it still affected my skin by causing these problems.
Age: 6.0
Sex: M
Vaccine: FLUX
Symptoms: Injection site pain, Oedema
Clinical narrative: Flu Vaccine given, extreme soarness at site and swelling in armpit lasting 9 days
Age: 67.0
Sex: F
Vaccine: UNK
Symptoms: Myalgia
Clinical narrative: Whole body started aching and lasted 1 3/4 years. Shoulders, hips, knees, etc. Medication did not work, acupuncture did not work. Slowly after 1 3/4 years it finally got better.
Age: 23.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Pneumonia, Pyrexia, Rash maculo-papular, Rash vesicular
Clinical narrative: Information has been received from a physician concerning a 24 year old female pt with hypopituitarism, epilepsy and mental retardation (severity unspecified) who on 4/19/02 was vaccinated SC in the arm with a first dose of varicella virus vaccine live (lot 638814/0558L, dilutent lot 640750/0997L). No adverse events were reported following prior vaccinations. Concomitant therapy included hydrocortisone (manuf unk), 7.5TID (strength unk) and levothyroxine Na 125 dialy (strength unk). On 5/7/02 the pt developed a maculoopapular vesicular rash on her trunk, face and extremities, fever and pneumonia. The pt was also tested for Varicella IgM and IgG which were reported as negative. The pt required hospitalization for a total of 8 days. It was also reported that from 5/8/02 through 5/20/02, the pt was treated with acyclovir. Subsequently, the pt recovered. Additional info has been requested.
Age: 23.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Pneumonia, Pyrexia, Rash macular, Rash papular, Rash vesicular
Clinical narrative: Information has been received from a physician concerning a 24 year old female pt with hypopituitarism, epilepsy and mental retardation (severity unspecified) who on 4/19/02 was vaccinated SC in the arm with a first dose of varicella virus vaccine live (lot 638814/0558L, dilutent lot 640750/0997L). No adverse events were reported following prior vaccinations. Concomitant therapy included hydrocortisone (manuf unk), 7.5TID (strength unk) and levothyroxine Na 125 dialy (strength unk). On 5/7/02 the pt developed a maculoopapular vesicular rash on her trunk, face and extremities, fever and pneumonia. The pt was also tested for Varicella IgM and IgG which were reported as negative. The pt required hospitalization for a total of 8 days. It was also reported that from 5/8/02 through 5/20/02, the pt was treated with acyclovir. Subsequently, the pt recovered. Additional info has been requested.
Sex: M
Vaccine: HEP
Symptoms: Drug toxicity, Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: Information has been received from a legal firm regarding a case in litigation concerning a male who on 10/16/96 was vaccinated with hep B vaccine recombinant (no batch reported, manuf unk). Other immunizations included the following vaccines Acel-Imune (lot 434814 given on 12/9/96) (lot 441-103 given on 4/29/97) (lot 453-846 given on 10/19/98), hep B vaccine recombinant (Engerix B) (lot 2137A2 given on 12/9/96) (lot 2149A2 given on 4/29/97), Tripedia (lot 7L81673 given on 2/26/98), haemophilus B conjugate vaccine (lot M200RC given on 2/26/98, manuf unk) and HibTITER (lot M040RL given on 10/19/98). It is alleged that the pt developed severe neurodevelopmental disorders with associated high mercury exposure levels, mercury poisoning by the cumulative dose of mercury in thimerosal, and now suffers, and in the future will continue to suffer from toxic neurological effects of mercury poisoning. It was reported that the pt was exposed to very high doses of mercury contained in thimerosal from vaccinations administered during the period from October 1996 through at least October 1998. Upon internal review, severe neurodevelopmental disorders, mercury poisoning, and toxic neurological effects of mercury poisoning were considered other important medical events (OMIC). No further info is available.
Sex: M
Vaccine: DTPHIB, HEP
Symptoms: Drug toxicity, Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: Information has been received from a legal firm regarding a case in litigation concerning a male who on 1/6/95 and 2/8/95 was vaccinated with hep B vaccine recombinant (lot 612504/0873A for both reported). Other immunizations included the following vaccines: Tetramune (lot 386987 given on 2/8/95) (lot 386988 given on 4/13/95) (lot 394957 given on 6/21/95), hep B vaccine, recomb (Engerix B) (lot 1513B2 given on 9/28/95), HibTITER (lot M3051F gvien on 4/4/95), Tripedia (lot 5K61015 given on 4/4/96) and diphtheria toxoid/tetanus toxoid vaccine (lot 0985990 given on 8/11/00). It is alleged that the pt developed severe neurodevelopmental disorders with associated high mercury exposure levels, mercury poisoning by the cumulative doses of mercury in the thimerosal, and toxic neurological effects of mercury poisoning which he now suffers and will continue to suffer. The pt was exposed to vaccines reportedly containing thimerosal and administered to him during the first years of his life, during the period from January 1995 through at least August 2000. Upon internal review, severe neurodevelpmental disorders, mercury poisoning, and toxic neurolgoical effects of mercury poisoning were considered to be other important medical events (OMIC). No further info is available.